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Background
The Calcium Dependent Antibiotic (CDA) from S. coeli-
color is a non-ribosomally synthesised lipopeptide which
consists of 11 amino acids to which a lipid part has been
attached [1]. Although the mode of action for CDA is not
yet known, antibiotics with similar structure like dapto-
mycin or friulimicin inhibit bacterial cell wall synthesis.
CDA-related drugs therefore, may become very important
in treating infections from severe antibiotic resistant path-
ogens, such as methicillin-resistant Staphylococcus aureus
strains (MRSA) and vancomycin-resistant enterococci
(VRE). CDA contains several nonproteinogenic amino
acids, crucially L-4-hydroxyphenylglycine (HPG). This
amino acid is also present in the backbone of various
important therapeutics such as; peptides (complestatin
and nocardicin), glycopeptides, (vancomycin and teico-
planin), further lipopeptides (arylomycin), and the
lipoglycodepsipeptide antibiotic ramoplanin.
Model construction
In this work, a metabolic model for S. coelicolor was con-
structed using the metabolic flux analysis approach [2].
The metabolic model involved around 250 reactions of
the primary and secondary metabolism leading to CDA
formation. We used the model for in silico experimenta-
tion and prediction of the internal metabolite fluxes
under different conditions during S. coelicolor fermenta-
tion, either for the maximisation of growth or CDA pro-
duction using linear programming in GAMS software.
Results
The comparison of internal metabolite fluxes between the
maximisation of growth and CDA production revealed
important changes in fluxes related to NADPH (Pentose
Phosphate pathway), CDA amino acid precursors (serine,
glycine, HPG and tryptophan) and NADH. We are now
using this model in predictive mode in order to develop
strategies to increase CDA productivity; such as, media
formulation, precursor addition and identification of
genetic engineering targets.
Conclusion
Computational metabolic flux analysis can be used in
order to study the interrelationship between the primary
metabolism and biosynthetic pathways for CDA, as well
as for the in silico experimentation for the identification of
genetic engineering targets for increased production. It
can also be used to investigate any precursor effects for
precursor-directed biosynthesis combined with genetic
engineering.
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